Company intelligence / Profile preview

Hurdle Star

Ownership: Private
Employees: ~75
Development stage: Other

Overview

Hurdle provides an integrated suite of diagnostic solutions leveraging multi-modal data and AI to accelerate biomarker discovery and validation. Their platform enables patient stratification and novel clinical endpoints for precision medicine. The company focuses on making biology data accessible and actionable for healthcare providers, clinics, digital health companies, diagnostics firms, and research institutions.

Therapeutic areas: Other
Modalities: Diagnostic platformMulti-omics biomarker discoveryAI-driven analytics
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Not specifically listed; collaborates with clinics, digital health providers, diagnostics companies & research institutions as customers/partners.

Beyond the preview

Go deeper on Hurdle Star.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hurdle Star.

Explore the full profile